Back to dashboard
Medicare AdvantageCoverageMedium impact

Injections for Chronic Pain Conditions - Medicare Advantage (Revised)

Humana·Pain Management, Anesthesiology, PM&R (Physical Medicine & Rehab) +2 more·Medicare Advantage
Effective date
Not stated
We identified it
Aug 4, 2026
Days to comply

Summary

Humana Medicare Advantage has clarified coverage for chronic pain injections, including epidural steroid injections, facet joint injections, sacroiliac joint injections, trigger point injections, dry needling, and peripheral nerve blocks. These may be used for diagnostic or therapeutic purposes as part of pain management programs. This is a summary-only policy update without specific billing code guidance or detailed coverage criteria.

Action Required

Action needed
Immediately: Billing team should review this policy clarification for Humana Medicare Advantage plans. Verify that all chronic pain injection procedures currently being billed are documented as either diagnostic or therapeutic and are part of an established pain management program. No immediate billing system changes are required, but flag any chronic pain injection claims previously denied by Humana MA for reconsideration review. Contact Humana for specific prior authorization requirements, medical necessity criteria, and frequency limits, as this summary does not provide those details. Ensure providers document the clinical purpose (diagnostic vs. therapeutic) on all injection claims going forward.